Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.

@article{Williams2011DynamicMC,
  title={Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.},
  author={Ross Williams and John M. Hudson and Brendan A Lloyd and Ahthavan R Sureshkumar and Gordon Lueck and Laurent Milot and Mostafa Atri and Georg A. Bjarnason and Peter N. Burns},
  journal={Radiology},
  year={2011},
  volume={260 2},
  pages={581-90}
}
PURPOSE To develop and implement an evidence-based protocol for characterizing vascular response of renal cell carcinoma (RCC) to targeted therapy by using dynamic contrast material-enhanced (DCE) ultrasonography (US). MATERIALS AND METHODS The study was approved by the institutional research ethics board; written informed consent was obtained from all patients. Seventeen patients (four women; median age, 58 years; range, 42-72 years; 13 men, median age, 62 years; range, 45-81 years) with… CONTINUE READING